Case Study--Managing newly diagnosed type-2 diabetes

Bostock-Cox, Beverley
June 2010
Independent Nurse;6/4/2010, p1
Case Study
The article presents a case study of a 58-year old man, Charlie, who underwent an axillary abscess and was diagnosed as a possible candidate for diabetes. Several changes in his lifestyle and dietary habits for reducing risks of cardiovascular diseases and a continuous monitoring routine were prescribed to him. A framework that should be applied to all patients suffering from type-2 diabetes is presented. Diet, exercise and hypoglycaemic agents as a part of the intervention have been stated.


Related Articles

  • Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data.  // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p6 

    The article presents a research which examines the efficacy of cardiovascular (CV) safety of the selective dipeptidyl peptidase-4 (DPP-4) inhibitor saxagliptin for the treatment of type 2 diabetes mellitus (T2DM). It is reported that, the researchers carried out a retrospective meta-analysis to...

  • Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes. Haak, Thomas // Clinical Medicine Insights: Endocrinology & Diabetes;2015, Issue 8, p1 

    Type 2 diabetes mellitus (T2DM) is a progressive condition requiring long-term treatment. Most patients with T2DM are unable to maintain normoglycemia using metformin alone; thus, combination therapy is a pivotal part of disease management. Addition of the dipeptidyl peptidase-4 inhibitor...

  • Diabetes progresses more rapidly in kids.  // Clinical Advisor;Jul2013, Vol. 16 Issue 7, p25 

    The article reports on the results of the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study which found that diabetes progresses more rapidly in children.

  • Controlling diabetes.  // Mayo Clinic Health Letter;Sep2014, Vol. 32 Issue 9, p1 

    The article discusses how to control the disease called diabetes, particularly Type 1 and type 2 diabetes. It cites the importance of controlling blood glucose levels in the long term because extra glucose in the bloodstream will result in such ailments as heart disease, kidney disease, and eye...

  • Meeting glycemic goals: Options beyond metformin. DeBenederte, Valerie // Drug Topics;Nov2012 Supplement, p8s 

    The article discusses the options in drug treatment for type 2 diabetes patients beyond the use of metformin in controlling glycemic and glycosylated hemoglobin (HbA1c) levels. Clinical professor Stefanie C. Nigro explains that approaches in diabetes management and patient care plan may differ...

  • Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis. Gu, Shuyan; Shi, Jihao; Tang, Zhiliu; Sawhney, Monika; Hu, Huimei; Shi, Lizheng; Fonseca, Vivian; Dong, Hengjin // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: Metformin is the first-line oral hypoglycemic agent for type 2 diabetes mellitus recommended by international guidelines. However, little information exists comparing it with acarbose which is also commonly used in China. This study expanded knowledge by combining direct and...

  • Vildagliptin: a new treatment for type 2 diabetes. Lyon, Sue // British Journal of Hospital Medicine (17508460);Jun2008, Vol. 69 Issue 6, p316 

    The article reports that the dipeptidyl peptidase-4 inhibitor vildagliptin has been found to offer an effective treatment of type 2 diabetes. Two studies have observed that 100 mg of vildagliptin with metformin monotherapy can result in a 1.1 percent decrease in glycosylated hemoglobin compared...

  • ADVERSE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Pravinkumar, V. Ingle; Gokul, S. Talele // Asian Journal of Pharmaceutical & Clinical Research;Jan-Mar2012 Supplement, p108 

    In type 2 diabetes mellitus, it is considered that the lowered insulin secretion and the lowered insulin sensitivity cause hyperglycaemia. Sulfonylureas have strong blood-glucose lowering effect by stimulating insulin secretion and have been widely used in the treatment of type 2 diabetes....

  • Metformin Associated with Less Need for a Second Medicine. SHAUGHNESSY, ALLEN F. // American Family Physician;2/15/2015, Vol. 91 Issue 4, p261 

    The article discusses a study which investigated the initial treatment of type 2 diabetes using oral hypoglycemics other than metformin. Topics discussed include possible cardiovascular event in patients that initially took a sulfonylurea, higher cost of treatment associated with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics